IIPLA Newsroom Access

Continue with Google to unlock the newsroom.

Use Google SSO for the fastest sign-in experience across IP news, saved access limits, and member-only newsroom features. You can still choose another login method if you prefer.

Continue with GoogleUse another sign-in option
Thursday, April 30, 2026
Sign in with SSO
IIPLA Newsroom

IIPLA News

Daily reporting, analysis, and legal-market coverage across patents, trademarks, copyright, licensing, disputes, and policy.

SectionsHomeBlogMembershipLogin
Showing the newsroom archive for Thu, Apr 30, 2026.
Return to latest coverage
Browse by region and category
All regionsGlobalUSAIndiaChinaEuropeMiddle EastAfricaSoutheast AsiaLatin AmericaUK
All categoriesPatentsTrademarksCopyrightBrandsLitigationLicensingPolicyAI & IPEnforcementCounterfeitingTrade SecretsDomain / Digital Rights
News Archive

Thu, Apr 30, 2026

1 article published on this day, newest first.

Stayble Therapeutics to Seek Shareholder Approval for Liquidation and IP Asset Sale
PatentsGlobal

Stayble Therapeutics to Seek Shareholder Approval for Liquidation and IP Asset Sale

Extraordinary general meeting set for May 7 as Swedish biotech firm faces funding shortfall for STA363 project

Stayble Therapeutics AB, a Swedish biotechnology company specializing in injectable treatments for chronic back pain, has called an extraordinary general meeting on May 7 to vote on a proposal for voluntary liquidation. The board's recommendation follows unsuccessful efforts to secure partnerships or financing for its…

Thursday, April 30, 2026
IIPLA News Desk
Page 1 of 1
Previous1Next
Newsroom tools
Newsletters & Digests

Subscribe to IIPLA Newsroom

Get Top 5 IP News Today, weekly editorial roundups, and region-aware updates tailored to your practice.

Choose your regions
Choose your categories
By subscribing, you agree to receive IIPLA newsroom emails. You can update preferences or unsubscribe anytime.
Top 5 IP News Today

Essential reading

Open archive
1
GlobalPatents

Stayble Therapeutics to Seek Shareholder Approval for Liquidation and IP Asset Sale

Stayble Therapeutics AB, a Swedish biotechnology company specializing in injectable treatments for chronic back pain, has called an extraordinary general meeting on May 7 to vote on a proposal for voluntary liquidation. The board's recommendation follows unsuccessful efforts to secure partnerships or financing for its…

Thursday, April 30, 2026
Most Read

Popular with readers

IP News

Becton Dickinson Sues Baxter Over Infusion Pump Patents

Leading medical technology company Becton Dickinson and Company (BD) has filed a patent infringement lawsuit against Baxter International Inc., claiming that Baxter has unlawfully used BD’s patented technologies in it...

Wednesday, May 14, 2025
IIPLA News Desk
IP Blog

Detailed Information About PCT Filing

Regularly check our site to learn about PCT filing and more crucial ideas. The patent Cooperation Treaty is known as PCT. It is an international agreement that has more than 150 members. Submitting a single PCT applic...

Saturday, August 13, 2022
memonhusen